Next Article in Journal
Porcine Protein Hydrolysates (PEPTEIVA®) Promote Growth and Enhance Systemic Immunity in Gilthead Sea Bream (Sparus aurata)
Next Article in Special Issue
Beclin 1, LC3 and P62 Expression in Equine Sarcoids
Previous Article in Journal
Assessment of Meat-Type Sheep Welfare Using Animal-Based Measures
 
 
Article

PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas

1
Dipartimento di Medicina Veterinaria, Università degli Studi di Perugia, 06126 Perugia, Italy
2
Centro di Ricerca sul Cavallo Sportivo, Università degli Studi di Perugia, 06126 Perugia, Italy
3
Dipartimento di Scienze Medico-Veterinarie, Università degli Studi di Parma, 43100 Parma, Italy
4
Pathology Institute, University of Veterinary Medicine, 30545 Hannover, Germany
5
Azienda Usl Toscana Nord-Ovest, UOC Ostetricia e Ginecologia, Ospedale Apuane, 54100 Massa, Italy
6
IZSLPV, Centro di Referenza di Oncologia Veterinaria e Comparata (CEROVEC), 16129 Genova, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Romain Paillot
Animals 2021, 11(7), 2121; https://doi.org/10.3390/ani11072121
Received: 25 May 2021 / Revised: 13 July 2021 / Accepted: 14 July 2021 / Published: 16 July 2021
(This article belongs to the Special Issue Papillomavirus Associated Diseases in Different Species)
In the last few years, the treatment of different types of tumors in humans has benefited from the introduction of new drugs called “immune checkpoint inhibitors” (ICI). These treatments help the patient’s immune response in fighting against cancer, therefore limiting tumor growth and aggressiveness. The possibility to use this therapeutical strategy also in pet animals such as horses has been scarcely explored in veterinary medicine. This study aims at investigating the presence and expression of specific checkpoint molecules such as PD-L1 and CTLA-4 in penile tumors of horses, particularly regarding malignant squamous cell carcinomas. In fact, PD-L1 and CTLA-4 presence is pivotal for an effective response to ICI and a successful therapy. Unfortunately, our results seem to indicate that these molecules are not frequently expressed in equine penile tumors. Therefore, horses with penile tumors may not benefit from the therapeutical use of ICI.
In horses, penile squamous cell carcinomas (epSCCs) are among the most common cutaneous neoplastic lesions. These tumors usually arise in benign lesions such as viral plaques and papillomas frequently induced by Equus caballus papillomavirus type 2 (EcPV2) infection. In the last decade, the introduction of immune checkpoint inhibitors (ICI) for the treatment of human cancers has demonstrated promising results. Among the most commonly targeted pathways, there is PD-1/PD-L1 and CTLA-4. The aim of this study is to investigate the expression of the PD-1/PD-L1 pathway and CTLA-4 in the tumor microenvironment of epSCCs to assess the feasibility of an immunotherapeutic approach. Twenty equine epithelial tumors were retrospectively selected and submitted to RT-qPCR for PD-1 and PD-L1 genes. After testing antibodies cross-reactivity by western blotting, immunohistochemistry for PD-L1 and CTLA-4 was performed. Results from RT-qPCR demonstrated that 3/20 cases expressed the PD-L1 gene, whereas the PD-1 gene was not detected. Immunohistochemical positivity for PD-L1 was found only in one case. CTLA-4-positive cells were observe in all cases but were few (Mdn = 4.8; IQR = 2.3–7.1 cells/HPF). In this study group, PD-1/PD-L1 and CTLA-4 do not appear to be highly expressed and therefore the use of ICI in epSCCs may not have promising rates of response. View Full-Text
Keywords: penile cancer; horse; papillomavirus; PD-L1; PD-1; CTLA-4; carcinoma; squamous cell; animal models; immune checkpoint inhibitors penile cancer; horse; papillomavirus; PD-L1; PD-1; CTLA-4; carcinoma; squamous cell; animal models; immune checkpoint inhibitors
Show Figures

Figure 1

MDPI and ACS Style

Porcellato, I.; Mecocci, S.; Brachelente, C.; Cappelli, K.; Armando, F.; Tognoloni, A.; Chiaradia, E.; Stefanetti, V.; Mechelli, L.; Pepe, M.; Gialletti, R.; Passeri, B.; Ghelardi, A.; Razzuoli, E. PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas. Animals 2021, 11, 2121. https://doi.org/10.3390/ani11072121

AMA Style

Porcellato I, Mecocci S, Brachelente C, Cappelli K, Armando F, Tognoloni A, Chiaradia E, Stefanetti V, Mechelli L, Pepe M, Gialletti R, Passeri B, Ghelardi A, Razzuoli E. PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas. Animals. 2021; 11(7):2121. https://doi.org/10.3390/ani11072121

Chicago/Turabian Style

Porcellato, Ilaria, Samanta Mecocci, Chiara Brachelente, Katia Cappelli, Federico Armando, Alessia Tognoloni, Elisabetta Chiaradia, Valentina Stefanetti, Luca Mechelli, Marco Pepe, Rodolfo Gialletti, Benedetta Passeri, Alessandro Ghelardi, and Elisabetta Razzuoli. 2021. "PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas" Animals 11, no. 7: 2121. https://doi.org/10.3390/ani11072121

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop